The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer

1. Diaz, R.
2. Nguewa, P.A.
3. Diaz-Gonzalez, J.A.
4. Hamel, E.
5. Gonzalez-Moreno, O.
6. Catena, R.
7. Serrano, D.
8. Redrado, M.
9. Sherris, D.
10. Calvo, A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1038/SJ.BJC.6604938 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus